Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Chronic Idiopathic Intestinal Pseudo-Obstruction

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Chronic Idiopathic Intestinal Pseudo-Obstruction in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
McQuade, RM1
Singleton, LM1
Wu, H1
Lee, S1
Constable, R1
Di Natale, M1
Ringuet, MT1
Berger, JP1
Kauhausen, J1
Parish, CL1
Finkelstein, DI1
Furness, JB1
Diwakarla, S1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Chronic Idiopathic Intestinal Pseudo-Obstruction

ArticleYear
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease.
    Scientific reports, 2021, 04-12, Volume: 11, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Animals; Cell Count; Chronic Disease; C

2021